APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carmustine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Carmustine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchCarmustine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Carmustine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Carmustine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carmustine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Carmustine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Carmustine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Carmustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Carmustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carmustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Carmustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carmustine include Eisai, Tianjin Kingyork, Zydus Pharmaceuticals, Bristol-Myers Squibb, STI Pharma, Sanli Ilac, Pharmaplan, Obvius Pharmaceuticals and Navinta, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Carmustine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Carmustine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Carmustine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Carmustine market size, projected growth trends, production technologies, key applications, and end-use industries.

Carmustine Segment by Company

Eisai

Tianjin Kingyork

Zydus Pharmaceuticals

Bristol-Myers Squibb

STI Pharma

Sanli Ilac

Pharmaplan

Obvius Pharmaceuticals

Navinta

MGI Pharma

Marcan Pharmaceuticals

Emcure Pharms

Arbor Pharms

Amneal Pharms

Carmustine Segment by Type

100mg Injection

125mg Injection

Carmustine Segment by Application

Medulloblastoma and Astrocytoma

Multiple Myeloma

Glioblastoma Multiforme

Lymphoma

Glioma

Others

Carmustine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carmustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carmustine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carmustine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Carmustine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carmustine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Carmustine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Carmustine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Carmustine Industry Trends Table 2. Carmustine Industry Drivers Table 3. Carmustine Industry Opportunities and Challenges Table 4. Carmustine Industry Restraints Table 5. Global Carmustine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Carmustine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Carmustine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Carmustine Sales Market Share by Manufacturers Table 9. Global Carmustine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Carmustine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Carmustine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Carmustine Manufacturers, Product Type & Application Table 13. Global Carmustine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Carmustine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg Injection Table 17. Major Manufacturers of 125mg Injection Table 18. Global Carmustine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Carmustine Sales by Type (2021-2026) & (k units) Table 20. Global Carmustine Sales by Type (2027-2032) & (k units) Table 21. Global Carmustine Sales Market Share by Type (2021-2026) Table 22. Global Carmustine Sales Market Share by Type (2027-2032) Table 23. Global Carmustine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Carmustine Revenue by Type (2021-2026) & (k units) Table 25. Global Carmustine Revenue by Type (2027-2032) & (k units) Table 26. Global Carmustine Revenue Market Share by Type (2021-2026) Table 27. Global Carmustine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Medulloblastoma and Astrocytoma Table 29. Major Manufacturers of Multiple Myeloma Table 30. Major Manufacturers of Glioblastoma Multiforme Table 31. Major Manufacturers of Lymphoma Table 32. Major Manufacturers of Glioma Table 33. Major Manufacturers of Others Table 34. Global Carmustine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Carmustine Sales by Application (2021-2026) & (k units) Table 36. Global Carmustine Sales by Application (2027-2032) & (k units) Table 37. Global Carmustine Sales Market Share by Application (2021-2026) Table 38. Global Carmustine Sales Market Share by Application (2027-2032) Table 39. Global Carmustine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Carmustine Revenue by Application (2021-2026) & (k units) Table 41. Global Carmustine Revenue by Application (2027-2032) & (k units) Table 42. Global Carmustine Revenue Market Share by Application (2021-2026) Table 43. Global Carmustine Revenue Market Share by Application (2027-2032) Table 44. Global Carmustine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Carmustine Sales by Region (2021-2026) & (k units) Table 46. Global Carmustine Sales Market Share by Region (2021-2026) Table 47. Global Carmustine Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Carmustine Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Carmustine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Carmustine Sales by Country (2021-2026) & (k units) Table 51. North America Carmustine Sales by Country (2027-2032) & (k units) Table 52. Europe Carmustine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Carmustine Sales by Country (2021-2026) & (k units) Table 54. Europe Carmustine Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Carmustine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Carmustine Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Carmustine Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Carmustine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Carmustine Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Carmustine Sales by Country (2027-2032) & (k units) Table 61. Global Carmustine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Carmustine Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Carmustine Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Carmustine Revenue Market Share by Region (2021-2026) Table 65. Global Carmustine Revenue Market Share by Region (2027-2032) Table 66. Eisai Company Information Table 67. Eisai Business Overview Table 68. Eisai Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Eisai Carmustine Product Portfolio Table 70. Eisai Recent Development Table 71. Tianjin Kingyork Company Information Table 72. Tianjin Kingyork Business Overview Table 73. Tianjin Kingyork Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Tianjin Kingyork Carmustine Product Portfolio Table 75. Tianjin Kingyork Recent Development Table 76. Zydus Pharmaceuticals Company Information Table 77. Zydus Pharmaceuticals Business Overview Table 78. Zydus Pharmaceuticals Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Zydus Pharmaceuticals Carmustine Product Portfolio Table 80. Zydus Pharmaceuticals Recent Development Table 81. Bristol-Myers Squibb Company Information Table 82. Bristol-Myers Squibb Business Overview Table 83. Bristol-Myers Squibb Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Bristol-Myers Squibb Carmustine Product Portfolio Table 85. Bristol-Myers Squibb Recent Development Table 86. STI Pharma Company Information Table 87. STI Pharma Business Overview Table 88. STI Pharma Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. STI Pharma Carmustine Product Portfolio Table 90. STI Pharma Recent Development Table 91. Sanli Ilac Company Information Table 92. Sanli Ilac Business Overview Table 93. Sanli Ilac Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Sanli Ilac Carmustine Product Portfolio Table 95. Sanli Ilac Recent Development Table 96. Pharmaplan Company Information Table 97. Pharmaplan Business Overview Table 98. Pharmaplan Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Pharmaplan Carmustine Product Portfolio Table 100. Pharmaplan Recent Development Table 101. Obvius Pharmaceuticals Company Information Table 102. Obvius Pharmaceuticals Business Overview Table 103. Obvius Pharmaceuticals Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Obvius Pharmaceuticals Carmustine Product Portfolio Table 105. Obvius Pharmaceuticals Recent Development Table 106. Navinta Company Information Table 107. Navinta Business Overview Table 108. Navinta Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Navinta Carmustine Product Portfolio Table 110. Navinta Recent Development Table 111. MGI Pharma Company Information Table 112. MGI Pharma Business Overview Table 113. MGI Pharma Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. MGI Pharma Carmustine Product Portfolio Table 115. MGI Pharma Recent Development Table 116. Marcan Pharmaceuticals Company Information Table 117. Marcan Pharmaceuticals Business Overview Table 118. Marcan Pharmaceuticals Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Marcan Pharmaceuticals Carmustine Product Portfolio Table 120. Marcan Pharmaceuticals Recent Development Table 121. Emcure Pharms Company Information Table 122. Emcure Pharms Business Overview Table 123. Emcure Pharms Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Emcure Pharms Carmustine Product Portfolio Table 125. Emcure Pharms Recent Development Table 126. Arbor Pharms Company Information Table 127. Arbor Pharms Business Overview Table 128. Arbor Pharms Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Arbor Pharms Carmustine Product Portfolio Table 130. Arbor Pharms Recent Development Table 131. Amneal Pharms Company Information Table 132. Amneal Pharms Business Overview Table 133. Amneal Pharms Carmustine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Amneal Pharms Carmustine Product Portfolio Table 135. Amneal Pharms Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Carmustine Distributors List Table 139. Carmustine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Carmustine Product Image Figure 2. Global Carmustine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carmustine Market Size (2021-2032) & (US$ Million) Figure 4. Global Carmustine Sales (2021-2032) & (k units) Figure 5. Global Carmustine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Carmustine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg Injection Image Figure 9. 125mg Injection Image Figure 10. Global Carmustine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Carmustine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Carmustine Sales Market Share by Type (2021-2032) Figure 13. Global Carmustine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Carmustine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Carmustine Revenue Market Share by Type (2021-2032) Figure 16. Medulloblastoma and Astrocytoma Image Figure 17. Multiple Myeloma Image Figure 18. Glioblastoma Multiforme Image Figure 19. Lymphoma Image Figure 20. Glioma Image Figure 21. Others Image Figure 22. Global Carmustine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Carmustine Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Carmustine Sales Market Share by Application (2021-2032) Figure 25. Global Carmustine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Carmustine Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Carmustine Revenue Market Share by Application (2021-2032) Figure 28. North America Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Carmustine Sales Market Share by Country (2021-2032) Figure 30. U.S. Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Carmustine Sales Market Share by Country (2021-2032) Figure 35. Germany Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Carmustine Sales Market Share by Country (2021-2032) Figure 42. China Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Carmustine Sales Market Share by Country (2021-2032) Figure 50. Brazil Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Carmustine Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Carmustine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Carmustine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Carmustine Revenue (2021-2032) & (US$ Million) Figure 61. North America Carmustine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Carmustine Revenue (2021-2032) & (US$ Million) Figure 63. Europe Carmustine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Carmustine Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Carmustine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Carmustine Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Carmustine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Carmustine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Carmustine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg Injection
  • 125mg Injection
Applications
  • Medulloblastoma and Astrocytoma
  • Multiple Myeloma
  • Glioblastoma Multiforme
  • Lymphoma
  • Glioma
  • Others
Companies covered
  • Eisai
  • Tianjin Kingyork
  • Zydus Pharmaceuticals
  • Bristol-Myers Squibb
  • STI Pharma
  • Sanli Ilac
  • Pharmaplan
  • Obvius Pharmaceuticals
  • Navinta
  • MGI Pharma
  • Marcan Pharmaceuticals
  • Emcure Pharms
  • Arbor Pharms
  • Amneal Pharms

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Carmustine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Carmustine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Carmustine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Carmustine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Carmustine Market Dynamics
  1. 2.1 Carmustine Industry Trends
  2. 2.2 Carmustine Industry Drivers
  3. 2.3 Carmustine Industry Opportunities and Challenges
  4. 2.4 Carmustine Industry Restraints
3 Carmustine Market by Manufacturers
  1. 3.1 Global Carmustine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Carmustine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Carmustine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Carmustine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carmustine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Carmustine Manufacturers, Product Type & Application
  7. 3.7 Global Carmustine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carmustine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carmustine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carmustine Tier 1, Tier 2, and Tier 3
4 Carmustine Market by Type
  1. 4.1 Carmustine Type Introduction
  2. 4.1.1 100mg Injection
  3. 4.1.2 125mg Injection
  4. 4.2 Global Carmustine Sales by Type
  5. 4.2.1 Global Carmustine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Carmustine Sales by Type (2021-2032)
  7. 4.2.3 Global Carmustine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Carmustine Revenue by Type
  9. 4.3.1 Global Carmustine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Carmustine Revenue by Type (2021-2032)
  11. 4.3.3 Global Carmustine Revenue Market Share by Type (2021-2032)
5 Carmustine Market by Application
  1. 5.1 Carmustine Application Introduction
  2. 5.1.1 Medulloblastoma and Astrocytoma
  3. 5.1.2 Multiple Myeloma
  4. 5.1.3 Glioblastoma Multiforme
  5. 5.1.4 Lymphoma
  6. 5.1.5 Glioma
  7. 5.1.6 Others
  8. 5.2 Global Carmustine Sales by Application
  9. 5.2.1 Global Carmustine Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Carmustine Sales by Application (2021-2032)
  11. 5.2.3 Global Carmustine Sales Market Share by Application (2021-2032)
  12. 5.3 Global Carmustine Revenue by Application
  13. 5.3.1 Global Carmustine Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Carmustine Revenue by Application (2021-2032)
  15. 5.3.3 Global Carmustine Revenue Market Share by Application (2021-2032)
6 Global Carmustine Sales by Region
  1. 6.1 Global Carmustine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Carmustine Sales by Region (2021-2032)
  3. 6.2.1 Global Carmustine Sales by Region (2021-2026)
  4. 6.2.2 Global Carmustine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Carmustine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Carmustine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Carmustine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Carmustine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Carmustine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Carmustine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Carmustine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Carmustine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Carmustine Revenue by Region
  1. 7.1 Global Carmustine Revenue by Region
  2. 7.1.1 Global Carmustine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Carmustine Revenue by Region (2021-2026)
  4. 7.1.3 Global Carmustine Revenue by Region (2027-2032)
  5. 7.1.4 Global Carmustine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Carmustine Revenue (2021-2032)
  8. 7.2.2 North America Carmustine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Carmustine Revenue (2021-2032)
  11. 7.3.2 Europe Carmustine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Carmustine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Carmustine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Carmustine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Carmustine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Carmustine Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Tianjin Kingyork
  8. 8.2.1 Tianjin Kingyork Company Information
  9. 8.2.2 Tianjin Kingyork Business Overview
  10. 8.2.3 Tianjin Kingyork Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tianjin Kingyork Carmustine Product Portfolio
  12. 8.2.5 Tianjin Kingyork Recent Developments
  13. 8.3 Zydus Pharmaceuticals
  14. 8.3.1 Zydus Pharmaceuticals Company Information
  15. 8.3.2 Zydus Pharmaceuticals Business Overview
  16. 8.3.3 Zydus Pharmaceuticals Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zydus Pharmaceuticals Carmustine Product Portfolio
  18. 8.3.5 Zydus Pharmaceuticals Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Carmustine Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
  25. 8.5 STI Pharma
  26. 8.5.1 STI Pharma Company Information
  27. 8.5.2 STI Pharma Business Overview
  28. 8.5.3 STI Pharma Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 STI Pharma Carmustine Product Portfolio
  30. 8.5.5 STI Pharma Recent Developments
  31. 8.6 Sanli Ilac
  32. 8.6.1 Sanli Ilac Company Information
  33. 8.6.2 Sanli Ilac Business Overview
  34. 8.6.3 Sanli Ilac Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanli Ilac Carmustine Product Portfolio
  36. 8.6.5 Sanli Ilac Recent Developments
  37. 8.7 Pharmaplan
  38. 8.7.1 Pharmaplan Company Information
  39. 8.7.2 Pharmaplan Business Overview
  40. 8.7.3 Pharmaplan Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharmaplan Carmustine Product Portfolio
  42. 8.7.5 Pharmaplan Recent Developments
  43. 8.8 Obvius Pharmaceuticals
  44. 8.8.1 Obvius Pharmaceuticals Company Information
  45. 8.8.2 Obvius Pharmaceuticals Business Overview
  46. 8.8.3 Obvius Pharmaceuticals Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Obvius Pharmaceuticals Carmustine Product Portfolio
  48. 8.8.5 Obvius Pharmaceuticals Recent Developments
  49. 8.9 Navinta
  50. 8.9.1 Navinta Company Information
  51. 8.9.2 Navinta Business Overview
  52. 8.9.3 Navinta Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Navinta Carmustine Product Portfolio
  54. 8.9.5 Navinta Recent Developments
  55. 8.10 MGI Pharma
  56. 8.10.1 MGI Pharma Company Information
  57. 8.10.2 MGI Pharma Business Overview
  58. 8.10.3 MGI Pharma Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MGI Pharma Carmustine Product Portfolio
  60. 8.10.5 MGI Pharma Recent Developments
  61. 8.11 Marcan Pharmaceuticals
  62. 8.11.1 Marcan Pharmaceuticals Company Information
  63. 8.11.2 Marcan Pharmaceuticals Business Overview
  64. 8.11.3 Marcan Pharmaceuticals Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Marcan Pharmaceuticals Carmustine Product Portfolio
  66. 8.11.5 Marcan Pharmaceuticals Recent Developments
  67. 8.12 Emcure Pharms
  68. 8.12.1 Emcure Pharms Company Information
  69. 8.12.2 Emcure Pharms Business Overview
  70. 8.12.3 Emcure Pharms Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Emcure Pharms Carmustine Product Portfolio
  72. 8.12.5 Emcure Pharms Recent Developments
  73. 8.13 Arbor Pharms
  74. 8.13.1 Arbor Pharms Company Information
  75. 8.13.2 Arbor Pharms Business Overview
  76. 8.13.3 Arbor Pharms Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Arbor Pharms Carmustine Product Portfolio
  78. 8.13.5 Arbor Pharms Recent Developments
  79. 8.14 Amneal Pharms
  80. 8.14.1 Amneal Pharms Company Information
  81. 8.14.2 Amneal Pharms Business Overview
  82. 8.14.3 Amneal Pharms Carmustine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Amneal Pharms Carmustine Product Portfolio
  84. 8.14.5 Amneal Pharms Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Carmustine Value Chain Analysis
  2. 9.1.1 Carmustine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Carmustine Production Mode & Process
  6. 9.2 Carmustine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Carmustine Distributors
  9. 9.2.3 Carmustine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst